|
|
|
|
You Are On :
Home | Company Profile | Company Background
|
|
|
|
Company
Background
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Natco |
|
|
|
BSE Code |
524816
|
|
ISIN Demat |
INE987B01026
|
|
Book Value (Rs) |
461.80
|
|
|
NSE Code |
NATCOPHARM
|
|
Dividend Yield (%) |
0.66
|
|
Market Cap (Rs Mn) |
161575.01
|
|
|
TTM PE(x) |
10.64
|
|
TTM EPS(Rs) |
84.75
|
|
Face Value(Rs.) |
2
|
|
|
|
|
|
|
|
|
|
|
Incorporation Year
|
19-09 1981
|
|
Registered Office
|
Natco House,Road No 2,Banjara Hills, Hyderabad,
Telangana-500034 .
|
|
ISINNO
|
INE987B01026
|
|
Phone
|
040-23547532
|
|
E-mail
|
investors@natcopharma.co.in / dasaradhi@natcopharma.co.in |
|
URL
|
www.natcopharma.co.in |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
V C Nannapaneni
|
|
Managing Director
|
V C Nannapaneni
|
|
Company Secretary
|
Chekuri Venkat Ramesh
|
|
Listing
|
BSE,NSE
|
|
|
|
|